BusinessAXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South KoreaBy Nasdaq OMXApr 3, 2018, 1:02 PM UTC
BusinessAXIM Biotech Enters Into Distribution Agreement for Proprietary Cannabinoid-Based Nutraceutical Chewing Gum Product CanChew+ Throughout ThailandBy Nasdaq OMXFeb 6, 2018, 2:59 PM UTC
BusinessAXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related PsychosisBy Nasdaq OMXAug 2, 2017, 1:01 PM UTC
BusinessAXIM Biotech Receives Schedule 1 Permit to Move Forward With Development of MedChew Rx Pharmaceutical Chewing GumBy Nasdaq OMXMay 2, 2017, 1:00 PM UTC
BusinessAXIM Biotech Announces the Production of CanChew Plus™, the Next Generation Controlled Release CBD Chewing GumBy Nasdaq OMXMar 1, 2017, 2:01 PM UTC
BusinessAXIM Biotech Announces the Production of CanChew Plus™, the Next Generation Controlled Release CBD Chewing GumBy Nasdaq OMXMar 1, 2017, 2:01 PM UTC
BusinessAXIM Biotech to Attend the 19th Annual BIO CEO & Investor Conference in New YorkBy Nasdaq OMXFeb 9, 2017, 2:02 PM UTC
